Skip to main content

Table 4 Mean difference and standard error between the SLT and placebo treatments for each EEG band and ERP component (all μV)

From: The effect of Sailuotong (SLT) on neurocognitive and cardiovascular function in healthy adults: a randomised, double-blind, placebo controlled crossover pilot trial

 

Mean Difference ± Standard Error

EEG Spectral Band

Eyes Open

Eyes Closed

 Delta

-1.64 ± -0.01

-0.07 ± -0.73

 Theta

-0.82 ± -0.37

0.20 ± -0.32

 Alpha

-0.16 ± 0.44

-3.66 ± -0.94

 Beta

2.14 ± 0.82

-0.65 ± -0.5

Visual ERP Component

Target

Nontarget

 N1

-1.72 ± -0.06

-0.45 ± -0.17

 P2

-0.37 ± -0.08

-0.69 ± 0.02

 N2

-0.74 ± -0.06

-0.05 ± -0.26

 P3a

2.58 ± 0.02

1.98 ± -0.20

 P3b

-1.12 ± 0.10

-1.38 ± -0.04

Auditory ERP Component

Target

Nontarget

  N1

2.14 ± 0.11

-1.38 ± -0.14

 P2

1.16 ± 0.84

-1.02 ± -0.31

 N2

-0.14 ± 1.78

-0.04 ± -0.13

  P3a

3.65 ± 0.07

-0.36 ± -0.08

 P3b

0.58 ± -0.25

-2.27 ± 0.10

  1. Note: The bolded ERP components had a treatment × time × stimulus type interaction (p < .10)